Notice of General Meeting
Released
Released
Announcement PDF
Felix Gold Limited (ASX.FXG)
ASX Announcement
18 November 2026
Notice of Meeting
Felix Gold Limited (ASX: FXG) is pleased to attach a copy of the following documents in relation to a General
Meeting of Shareholders to be held on 17 December 2026 at 10.00am (Brisbane Time) (General Meeting).
1. Letter to Shareholders regarding arrangements for the General Meeting as despatched to
Shareholders;
2. Notice of General Meeting; and
3. Proxy Form.
This announcement has been authorised for release by the Company Secretary.
ENDS
Enquiries
Joseph Webb
Executive Director
Felix Gold Limited
Ph: +61 422 955 411
E: joe.webb@felixgold.com.au
Felix Gold Limited (ASX.FXG)
Unit 11, 44 Station Road, Yeerongpilly QLD 4105
Tel: +61 7 3054 7108 ∙ Email: contact@felixgold.com.au ∙ Web: www.felixgold.com.au
18 November 2026
Dear Shareholders,
I am pleased to invite you to the General Meeting of Felix Gold Limited to be held at Unit 11, 44 Station
Road, Yeerongpilly QLD 4105, at 10:00am (AEST) on Thursday, 17 December 2026.
Notice of Meeting
The Notice of Meeting and Explanatory Memorandum (Notice) for the Meeting is available online and
can be viewed and downloaded by shareholders of the Company (Shareholders) from the Company’s
website at https://www.felixgold.com.au/announcements or the Company's ASX market
announcements platform at www.asx.com.au (ASX: FXG).
In accordance with Treasury Laws Amendments (2022 Measures No. 1) Act 2021, the Company will not
be sending hard copies of the Notice of Meeting to shareholders. If you have elected to receive notices by
email a communication will be sent to your nominated email address. If you have not elected to receive
notices by email a copy of your proxy form will be posted to you, together with this Letter.
To vote, Shareholders are strongly encouraged to submit their proxies as early as possible and in any
event prior to the cut-off for proxy voting as set out in the Notice.
Voting by Proxy
Online
scan the QR
code below
using your
smartphone
Lodge your Proxy vote online at https://singleholding.automic.com.au/en-AU/login by
following the below instructions:
1. Login to the Automic website using the holding details as shown on your
holding statement.
2. Click on ‘Meetings’ - ‘Vote’.
To use the online lodgment facility, Shareholders will need their holder number
(Securityholder Reference Number (SRN) or Holder Identification Number (HIN)) as
shown at the top of your holding statement.
For further information on the online proxy lodgement process, or if you require a hard copy Proxy
Form, please contact the Company’s Share Registry, Automic Registry Services (Automic), at
hello@automicgroup.com.au or via phone on 1300 288 664 (within Australia) or +61 2 9698 5414
(overseas).
Shareholders are also encouraged to submit questions in advance of the Meeting to the Company.
Questions may be submitted in writing to the Company Secretary at least five business days prior the
AGM by telephone on +61 7 3054 7108 or by email at cosec@felixgold.com.au.
Yours sincerely
Felix Gold Limited
Craig J McPherson
Company Secretary
FELIX GOLD LIMITED
ACN 645 790 281
Notice of General Meeting and Explanatory Memorandum
Date of Meeting: 17 December 2026
Time of Meeting: 10.00am (AEST)
Place of Meeting: Unit 11, 44 Station Road
Yeerongpilly QLD 4105
Notice of General Meeting
Notice is given that a General Meeting of Shareholders of Felix Gold Limited ACN 645 790 281
(Company) will be held at Unit 11, 44 Station Road, Yeerongpilly QLD 4105 on 17 December 2026 at
10.00am (AEST) (Meeting).
Capitalised terms used in this Notice of Meeting and the Explanatory Memorandum have the
meaning ascribed to them in the Glossary contained at the end of the Explanatory Memorandum.
This Notice of Meeting should be read in its entirety, together with the Explanatory Memorandum
and the enclosed proxy form.
1. Resolution 1 – Ratification of the issue of 41,250,000 Shares under the Placement
To consider and, if thought fit, to pass, with or without amendment, the following resolution as an
Ordinary Resolution:
“That, for the purposes of Listing Rule 7.4 and for all other purposes, the issue (or agreement to
issue) of 41,250,000 Shares by way of private placement to sophisticated, professional and
institutional investors, at an issue price of $0.12 per Share, in accordance with the terms set out in
the Explanatory Memorandum, be ratified.”
Voting exclusion for Resolution 1
The Company will disregard any votes cast in favour of Resolution 1 by or on behalf of a person
who participated in the issue of Shares the subject of Resolution 1 or is a counterparty to the
agreement being approved, or any of their Associates.
However, this does not apply to a vote cast in favour of Resolution 1 by:
(a) a person as proxy or attorney for a person who is entitled to vote on Resolution 1, in
accordance with directions given to the proxy or attorney to vote on Resolution 1 in that
way; or
(b) the Chair as proxy or attorney for a person who is entitled to vote on Resolution 1, in
accordance with a direction given to the Chair to vote on Resolution 1 as the Chair
decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on
behalf of a beneficiary provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is
not excluded from voting, and is not an Associate of a person excluded from voting,
on Resolution 1; and
(ii) the holder votes on Resolution 1 in accordance with directions given by the
beneficiary to the holder to vote in that way.
2. Resolution 2 – Approval to issue 833,334 Shares to Mr Ronnie Beevor (or his
nominated Associate) under the Placement
To consider and, if thought fit, to pass, with or without amendment, the following resolution as an
Ordinary Resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, the issue of 833,334 Shares
by way of private placement to Mr Ronnie Beevor (or his nominated Associate), at an issue price
of $0.12 per Share, in accordance with the terms set out in the Explanatory Memorandum, be
approved.”
Voting exclusion for Resolution 2
The Company will disregard any votes cast in favour of Resolution 2 by or on behalf of Mr Beevor
(or his nominated Associate), and any other person who will obtain a material benefit as a result
of the issue of the Shares to Mr Beevor (except a benefit arising solely from their capacity as a
holder of Shares) or any of their Associates.
However, this does not apply to a vote cast in favour of Resolution 2 by:
Notice of General Meeting
(a) a person as proxy or attorney for a person who is entitled to vote on Resolution 2, in
accordance with directions given to the proxy or attorney to vote on Resolution 2 in that
way; or
(b) the Chair as proxy or attorney for a person who is entitled to vote on Resolution 2, in
accordance with a direction given to the Chair to vote on Resolution 2 as the Chair
decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on
behalf of a beneficiary provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is
not excluded from voting, and is not an Associate of a person excluded from voting,
on Resolution 2; and
(ii) the holder votes on Resolution 2 in accordance with directions given by the
beneficiary to the holder to vote in that way.
3. Resolution 3 – Approval to issue 833,333 Shares to Mr Andrew Browne (or his
nominated Associate) under the Placement
To consider and, if thought fit, to pass, with or without amendment, the following resolution as an
Ordinary Resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, the issue of 833,333 Shares
by way of private placement to Mr Andrew Browne (or his nominated Associate), at an issue
price of $0.12 per Share, in accordance with the terms set out in the Explanatory Memorandum,
be approved.”
Voting exclusion for Resolution 3
The Company will disregard any votes cast in favour of Resolution 3 by or on behalf of Mr Browne
(or his nominated Associate), and any other person who will obtain a material benefit as a result
of the issue of the Shares to Mr Browne (except a benefit arising solely from their capacity as a
holder of Shares) or any of their Associates.
However, this does not apply to a vote cast in favour of Resolution 3 by:
(a) a person as proxy or attorney for a person who is entitled to vote on Resolution 3, in
accordance with directions given to the proxy or attorney to vote on Resolution 3 in that
way; or
(b) the Chair as proxy or attorney for a person who is entitled to vote on Resolution 3, in
accordance with a direction given to the Chair to vote on Resolution 3 as the Chair
decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on
behalf of a beneficiary provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is
not excluded from voting, and is not an Associate of a person excluded from voting,
on Resolution 3; and
(ii) the holder votes on Resolution 3 in accordance with directions given by the
beneficiary to the holder to vote in that way.
4. Resolution 4 – Approval to issue 833,333 Shares to Mr Blair Way (or his nominated
Associate) under the Placement
To consider and, if thought fit, to pass, with or without amendment, the following resolution as an
Ordinary Resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, the issue of 833,333 Shares
by way of private placement to Mr Blair Way (or his nominated Associate), at an issue price of
$0.12 per Share, in accordance with the terms set out in the Explanatory Memorandum, be
approved.”
Notice of General Meeting
Voting exclusion for Resolution 4
The Company will disregard any votes cast in favour of Resolution 4 by or on behalf of Mr Way
(or his nominated Associate), and any other person who will obtain a material benefit as a result
of the issue of the Shares to Mr Way (except a benefit arising solely from their capacity as a
holder of Shares) or any of their Associates.
However, this does not apply to a vote cast in favour of Resolution 4 by:
(a) a person as proxy or attorney for a person who is entitled to vote on Resolution 4, in
accordance with directions given to the proxy or attorney to vote on Resolution 4 in that
way; or
(b) the Chair as proxy or attorney for a person who is entitled to vote on Resolution 4, in
accordance with a direction given to the Chair to vote on Resolution 4 as the Chair
decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on
behalf of a beneficiary provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is
not excluded from voting, and is not an Associate of a person excluded from voting,
on Resolution 4; and
(ii) the holder votes on Resolution 4 in accordance with directions given by the
beneficiary to the holder to vote in that way.
5. Resolution 5 – Approval to issue up to 16,666,667 Shares to MDF Global Limited
(or its nominee(s)) under the Placement
To consider and, if thought fit, to pass, with or without amendment, the following resolution as an
Ordinary Resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, the issue of up to 16,666,667
Shares by way of private placement to MDF Global Limited (or its nominee(s)), at an issue price
of $0.12 per Share, in accordance with the terms set out in the Explanatory Memorandum, be
approved.”
Voting exclusion for Resolution 5
The Company will disregard any votes cast in favour of Resolution 5 by or on behalf of MDF (or
its nominee(s)), and any other person who will obtain a material benefit as a result of the issue
of the Shares to MDF (except a benefit arising solely from their capacity as a holder of Shares)
or any of their Associates.
However, this does not apply to a vote cast in favour of Resolution 5 by:
(a) a person as proxy or attorney for a person who is entitled to vote on Resolution 5, in
accordance with directions given to the proxy or attorney to vote on Resolution 5 in that
way; or
(b) the Chair as proxy or attorney for a person who is entitled to vote on Resolution 5, in
accordance with a direction given to the Chair to vote on Resolution 5 as the Chair
decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on
behalf of a beneficiary provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is
not excluded from voting, and is not an Associate of a person excluded from voting,
on Resolution 5; and
(ii) the holder votes on Resolution 5 in accordance with directions given by the
beneficiary to the holder to vote in that way.
By order of the Board
Mr Craig McPherson
Company Secretary
Explanatory Memorandum
The following notes and the Explanatory
Memorandum form part of the Notice of Meeting.
Voting and Attendance Entitlement
The Board has determined that those persons who
are registered as holding Shares as at 7.00 pm
(AEST) on 15 December 2026, will be entitled to
attend and vote at the Meeting.
Accordingly, transactions registered after that
time will be disregarded in determining
entitlements to attend and vote at the Meeting.
If more than one joint holder of a Share is present
at the Meeting (whether personally, by proxy, by
attorney or by representative) and tenders a vote,
only the vote of the joint holder whose name
appears first on the register will be counted.
Action to be Taken by Shareholders
A Shareholder who is entitled to attend and vote
at the Meeting may appoint a person, who need
not be a Shareholder of the Company, as the
Shareholder’s proxy to attend and vote on behalf
of the Shareholder.
A Shareholder who is entitled to cast 2 or more
votes may appoint 2 proxies and may specify the
proportion or number of votes each proxy is
appointed to exercise.
If you wish to indicate how your proxy should vote,
please mark the appropriate boxes on the proxy
form. If in respect of any of the items of business
you do not direct your proxy how to vote, you are
directing your proxy to vote as he or she decides.
If you mark the abstain box for a particular item
you are directing your proxy to not vote on your
behalf and your Shares will not be counted in
computing the required majority in the event of a
poll.
For proxies without voting instructions that are
exercisable by the Chair, the Chair intends to vote
those proxies in favour of the Resolutions. The
Chair will be deemed to be appointed where a
signed proxy form is returned that does not
contain the name of the proxy or where the
person appointed on the form is absent from the
Meeting.
A proxy form accompanies this Notice of
Meeting. Should you wish to appoint a proxy,
please complete the proxy form and return it at
least 48 hours before the Meeting, being no later
than 10.00am (AEST) on 15 December 2026 to:
(a) if by email: [●];
(b) if online: by visiting [●] and following the
instructions on your proxy form;
(c) if by mail:
Felix Gold Limited
C/- [●] [share registry]
[●]
[●]
If the appointment is signed by an attorney, the
power of attorney or a certified copy of it must be
sent with the proxy form.
Corporate Representatives
A Shareholder, which is a corporation, may
appoint an individual to act as its representative
to attend and vote at the Meeting. The
appointment must comply with section 250D of
the Corporations Act, meaning that the
Company will require a Certificate of
Appointment of Corporate Representative
executed in accordance with section 250D of the
Corporations Act. The completed certificate
should be lodged with Company’s share registry
before the Meeting or at the registration desk on
the day of the Meeting.
Polls
In accordance with section 250JA of the
Corporations Act, all Resolutions will be
determined by way of a poll and, as such, every
Shareholder shall have one vote for every Share
registered in their name as at 7.00 pm (AEST) on 15
December 2026.
Required Majority
Each of Resolutions 1 to 5 (inclusive) is an Ordinary
Resolution, requiring a simple majority of the votes
cast by Shareholders entitled to vote on them.
General
All Shareholders are invited to attend the Meeting
or, if they are unable to attend in person, to sign
and return the proxy form to the Company in
accordance with the instructions set out on the
proxy form.
Shareholders, their proxy or corporate
representatives who plan on attending the
Meeting are asked to arrive at the venue at least
30 minutes prior to the time the Meeting is
scheduled to commence, so that Shareholders
can be checked against the Company’s share
register, or appointment as proxy, attorney or
corporate representative can be verified and
their attendance noted.
Explanatory Memorandum
This Explanatory Memorandum contains an explanation of, and information about, the
Resolutions to be considered at the General Meeting. Shareholders should read this
Explanatory Memorandum in full. This Explanatory Memorandum forms part of the
accompanying Notice of Meeting and should be read with the Notice of Meeting.
This Explanatory Memorandum does not take into account the individual investment
objectives, financial situation and needs of individual Shareholders or any other person. If you
are in any doubt about what to do in relation to the Resolutions, you should consult your
financial or other professional adviser.
Capitalised words used in the Notice of Meeting and in this Explanatory Memorandum are
defined in the Glossary section at the end of this Explanatory Memorandum. Unless otherwise
stated, all references to sums of money, '$' and 'dollars' are references to Australian currency.
Capital Raising Background
On 4 November 2026, the Company announced that it had received binding commitments
for a private placement of 60,416,667 Shares, at an issue price of $0.12 per Share, to raise
approximately $7.25 million (before costs) from sophisticated, professional and institutional
investors, comprising:
(a) the issue of 41,250,000 Shares on or about 12 November 2026 to sophisticated,
professional and institutional investors, without Shareholder approval, utilising the
Company’s existing placement capacity under Listing Rule 7.1, to raise $4,950,000;
(b) an agreement to issue a total of 2,500,000 Shares to Mr Ronnie Beevor, Mr Andrew Browne
and Mr Blair Way, each a Director (or their nominated Associates), to raise $300,000,
which is conditional on Shareholder approval being obtained for those issues; and
(c) an agreement to issue up to 16,666,667 Shares to MDF Global Limited (or its nominee(s)),
to raise up to $2,000,000, which is conditional on Shareholder approval being obtained
for that issue,
(together, the Placement).
The issue price of $0.12 per Share represented a 14.3% discount to the last closing price of $0.14
on 30 October 2026, a 14.3% discount to the 5-day VWAP and a 20.5% discount to the 15-day
VWAP.
The Placement was managed by Morgans Corporate Limited and GBA Capital Pty Ltd
(together, the Joint Lead Managers).
The Company also announced a share purchase plan to raise up to $1 million (before costs)
offering eligible Shareholders (being Shareholders with a registered address in Australia or New
Zealand as at 7.00 pm (AEDT) on 3 November 2026) the opportunity to subscribe for up to
$30,000 of Shares at the same issue price as the Placement. Shares issued under the share
purchase plan fall within exception 5 of Listing Rule 7.2 and do not require Shareholder
approval.
The funds raised from the Placement, together with the Company’s existing cash, will be
applied to:
(a) completing the Treasure Creek mine permitting and economic study (approximately
$1.80 million);
Explanatory Memorandum
(b) Frontier refinery site selection, permitting and economic study, and negotiation of a
potential award following selection by the US Department of Energy (approximately
$1.30 million);
(c) drilling, an updated gold Mineral Resource estimate and antimony resource definition
(approximately $1.80 million); and
(d) corporate costs, the costs of the Placement and a cash buffer (approximately $3.65
million).
Resolution 1 – Ratification of the issue of 41,250,000 Shares under the Placement
Background
As outlined in the section of this Explanatory Memorandum titled “Capital Raising Background”,
on or about 12 November 2026 the Company will issue 41,250,000 Shares to sophisticated,
professional and institutional investors under the Placement, prior to the date of the Meeting.
The Shares will be issued without Shareholder approval under the Company’s existing
placement capacity as provided for by Listing Rule 7.1.
The Company now seeks Shareholder approval to ratify the issue (or agreement to issue) of the
Shares to sophisticated, professional and institutional investors pursuant to the Placement in
accordance with Listing Rule 7.4.
Listing Rules
Listing Rule 7.1 provides that an entity must not, subject to certain exemptions, issue or agree
to issue more Equity Securities during any 12-month period, than the amount which represents
15% of the number of fully paid ordinary securities on issue at the commencement of that 12-
month period without Shareholder approval.
Listing Rule 7.4 permits Shareholders to ratify a previous issue of, or agreement to issue, Equity
Securities in a general meeting, and provided that the previous issue or agreement did not
breach Listing Rule 7.1 when it was made, the issue or agreement will be deemed to have
been made with Shareholder approval for the purposes of Listing Rule 7.1. This will mean that
the Shares issued under the Placement will not be deducted from the Company’s placement
capacity under Listing Rule 7.1.
The issue of the Shares pursuant to the Placement will reduce the Company’s available
capacity under Listing Rule 7.1 to issue new Equity Securities.
Accordingly, the Company now seeks Shareholder approval to ratify the issue (or agreement
to issue) of the Shares pursuant to the Placement in accordance with Listing Rule 7.4.
If Resolution 1 is passed, the 41,250,000 Shares issued under the Placement will be excluded in
calculating the Company’s 15% placement capacity under Listing Rule 7.1. Therefore, the
Company will retain the flexibility to issue Equity Securities up to its 15% placement capacity
without the requirement to obtain prior Shareholder approval in the relevant period.
If Resolution 1 is not passed, the 41,250,000 Shares issued under the Placement will be included
in calculating the Company’s 15% placement capacity under Listing Rule 7.1, effectively
decreasing the number of Equity Securities that the Company can issue without Shareholder
approval over the 12-month period following the date of issue of the Shares. This means the
Company will have reduced flexibility to utilise its placement capacity to take advantage of
any commercial opportunities as they may arise.
Explanatory Memorandum
For the purposes of Listing Rule 7.5, the following information is provided in respect of Resolution
1:
Names of allottees The Shares will be issued to various professional, sophisticated and
institutional investors identified by the Company in consultation with
the Joint Lead Managers.
No Related Party, member of Key Management Personnel, substantial
(10%+) holder of the Company, adviser to the Company or any of their
respective Associates will be issued more than 1% of the Company’s
issued capital under the issue the subject of Resolution 1.
No Director, MDF or any of their Associates will participate in or receive
any Shares pursuant to Resolution 1. However, as set out elsewhere in
this Explanatory Memorandum, Mr Ronnie Beevor, Mr Andrew Browne
and Mr Blair Way (or their nominated Associates) and MDF (or its
nominee(s)) may receive Shares subject to the passing of Resolutions
2 to 5.
Number and class
of securities issued
The Company will issue 41,250,000 Shares under the Placement, which
will all rank, from their date of issue, equally with all other Shares on
issue. Of these, all will be issued under the Company’s placement
capacity under Listing Rule 7.1 and none will be issued under Listing
Rule 7.1A.
Date of issue The Shares are expected to be issued on or about 12 November 2026,
being prior to the date of the Meeting.
Issue price The issue price was $0.12 per Share. The Company will receive a total
of $4,950,000 (before costs) from the issue of the Shares to be ratified
pursuant to Resolution 1.
Purpose and use of
funds
The funds raised by the Placement will be used for the purposes
outlined in the section of this Explanatory Memorandum titled “Capital
Raising Background”.
Material terms of
agreement
The Shares will be issued under placement commitment letters which
provide that the issue price of Shares is $0.12 per Share and included
various other conditions customary for a placement of this sort.
Directors’ Recommendation
The Directors unanimously recommend that Shareholders vote in favour of Resolution 1 and
advise that they intend to vote any Shares that they own or control in favour of Resolution 1.
The Chair intends to vote all undirected proxies in favour of Resolution 1.
Resolutions 2, 3 and 4 – Approval to issue Shares to Mr Ronnie Beevor, Mr Andrew
Browne and Mr Blair Way (or their nominated Associates) under the Placement
Background
As outlined in the section of this Explanatory Memorandum titled “Capital Raising Background”,
the Directors set out below (Participating Directors) agreed, subject to Shareholder approval,
to participate in the Placement for a total of $300,000, at an issue price of $0.12 per Share
(being the same price as all other participants in the Placement), as follows:
Explanatory Memorandum
Participating Director Resolution Position Shares Subscription
amount
Mr Ronnie Beevor 2 Non-Executive
Chairman
833,334 $100,000
Mr Andrew Browne 3 Non-Executive
Director
833,333 $100,000
Mr Blair Way 4 Non-Executive
Director
833,333 $100,000
Total 2,500,000 $300,000
Listing Rules
Listing Rule 10.11 provides that, unless one of the exceptions in Listing Rule 10.12 applies, the
Company must not issue or agree to issue Equity Securities to a Related Party of the Company
without Shareholder approval.
As each of Mr Beevor, Mr Browne and Mr Way is a Related Party of the Company by virtue of
his position as a Director, each is a person falling within category 10.11.1 of Listing Rule 10.11,
and his nominated Associate (if any) is a person falling within category 10.11.4 of Listing Rule
10.11. None of the exceptions in Listing Rule 10.12 applies. Accordingly, Resolutions 2, 3 and 4
seek Shareholder approval for the issue of Shares under the Placement to each Participating
Director (or his nominated Associate) in accordance with Listing Rule 10.11.
Resolutions 2, 3 and 4 are separate resolutions and are not conditional on each other.
If Resolution 2, 3 or 4 (as applicable) is passed, the relevant Participating Director (or his
nominated Associate) will receive the Shares that he subscribed for under the Placement, and
the Company will receive the relevant subscription amount set out in the table above.
If Resolution 2, 3 or 4 (as applicable) is not passed, no Shares will be issued to the relevant
Participating Director (or his nominated Associate) as part of the Placement and any
application money received from him (or his nominated Associate) for the Shares will be
returned to him (without interest).
Shareholders should be aware that, if approval is given to issue Shares to the Participating
Directors (or their nominated Associates) under Listing Rule 10.11, approval will not be required
under Listing Rules 7.1 and 7.1A (in accordance with exception 14 of Listing Rule 7.2) and the
Shares issued to the Participating Directors (or their nominated Associates) will not be counted
towards the Company’s placement capacity.
Corporations Act
Under Chapter 2E of the Corporations Act, a public company cannot give a financial benefit
to a Related Party unless an exception applies or shareholders have in a general meeting
approved the giving of that financial benefit to the Related Party. Each Participating Director
is a Director and is therefore a Related Party of the Company.
In respect of each of Resolutions 2, 3 and 4, the Directors (other than the Participating Director
who is the subject of that Resolution) have formed the view that Shareholder approval under
section 208 of the Corporations Act is not required for the proposed issue of the Shares, on the
basis that the exception in section 210 of the Corporations Act applies, as each Participating
Explanatory Memorandum
Director is proposing to participate in the Placement on the same terms as other participants
in the Placement.
For the purposes of Listing Rule 10.13, the following information is provided in respect of
Resolutions 2, 3 and 4:
Names of allottees If Resolution 2 is passed, the Shares will be issued to Mr Ronnie Beevor
(or his nominated Associate).
If Resolution 3 is passed, the Shares will be issued to Mr Andrew Browne
(or his nominated Associate).
If Resolution 4 is passed, the Shares will be issued to Mr Blair Way (or his
nominated Associate).
10.11.1 – 10.11.5
Category
Each Participating Director is a Related Party of the Company by virtue
of his position as a Director and is therefore a person falling within
category 10.11.1 of Listing Rule 10.11. Any nominated Associate of a
Participating Director is a person falling within category 10.11.4 of
Listing Rule 10.11.
Number and class
of securities
If Resolution 2 is passed, 833,334 Shares will be issued to Mr Beevor (or
his nominated Associate).
If Resolution 3 is passed, 833,333 Shares will be issued to Mr Browne
Share your feedback
Discover